Indazole and indolone derivatives and their use as pharmaceuticals

Details for Australian Patent Application No. 2005247696 (hide)

Owner Pfizer, Inc.

Inventors Miller, Duncan Charles; Hepworth, David; Allerton, Charlotte Moira Norfor

Agent Allens Arthur Robinson

Pub. Number AU-A-2005247696

PCT Pub. Number WO2005/116027

Priority 0411810.5 26.05.04 GB; 0415455.5 09.07.04 GB

Filing date 17 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/454 (2006.01)

A61K 31/5377 (2006.01)

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/10 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/116027 Priority application(s): WO2005/116027

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247699-Aminopyridine derivatives as selective dopamine D3 agonists

2005247693-Tetraazabenzo[E]azulene derivatives and analogs thereof